ACADIA Pharmaceuticals Inc (ACAD)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 226,451 | -61,286 | -215,975 | -167,870 | -281,584 |
| Revenue | US$ in thousands | 957,797 | 726,437 | 517,235 | 484,145 | 441,755 |
| Net profit margin | 23.64% | -8.44% | -41.76% | -34.67% | -63.74% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $226,451K ÷ $957,797K
= 23.64%
Based on the provided data, ACADIA Pharmaceuticals Inc's net profit margin has shown significant fluctuations over the past five years. The net profit margin was negative in December 2020 at -63.74%, indicating that the company had a net loss relative to its revenue.
Over the following years, the net profit margin improved, albeit still in negative territory. By December 2021, the net profit margin had improved to -34.67%, and by December 2022, it further decreased to -41.76%. Although the company was still facing losses, the trend showed some improvement.
However, by December 2023, there was a notable turnaround with the net profit margin improving significantly to -8.44%. This indicates that the company had managed to reduce its losses relative to its revenue.
The most significant improvement was seen by December 2024, with the net profit margin turning positive at 23.64%. This suggests that ACADIA Pharmaceuticals Inc was able to generate a profit relative to its revenue, indicating a favorable financial performance compared to previous years.
Overall, the trend in the net profit margin of ACADIA Pharmaceuticals Inc indicates a path from significant losses to profitability over the five-year period, showing the company's efforts to improve its financial performance and efficiency.
Peer comparison
Dec 31, 2024